Annual report pursuant to Section 13 and 15(d)

Common Stock (Details Narrative)

v3.20.1
Common Stock (Details Narrative) - USD ($)
12 Months Ended
Nov. 05, 2019
Jun. 14, 2019
May 31, 2019
Apr. 18, 2019
Mar. 12, 2019
Feb. 07, 2019
Dec. 02, 2018
Nov. 27, 2018
Jun. 18, 2018
Jun. 12, 2018
Jun. 08, 2018
Jun. 04, 2018
May 30, 2018
May 01, 2018
Apr. 26, 2018
Dec. 31, 2019
Dec. 31, 2018
Number of common stock shares issued             2,005 3,334       1,500,000          
Number of common stock issed, value                               $ 3,319,656 [1] $ 6,082,444 [2]
Sale of stock price per share                       $ 5.00          
Sale of stock description                         Consisting of one share of the Company's common stock, par value $0.00001 per share (the "Common Stock"), and a warrant to purchase one share of common stock with an exercise price of $6.00 per share        
Common stock, par value                         $ 0.00001     $ 0.00001 $ 0.00001
Stock of warrant exercise price                         $ 6.00        
Gross proceeds from initial public offering                         $ 7,500,000     [3] $ 7,657,427 [3]
Stock-based compensation                               $ 941,962 1,922,455
Common stock percentage             25.00% 25.00%               50.00%  
Gross proceeds raised in private placement offering [4]                               $ 2,317,276
Boxer Parties [Member]                                  
Stock issued price per shares     $ 1.90                            
Number of restricted shares of common stock     157,000                            
Number of restricted shares of common stock value     $ 298,300                            
Consulting Agreement [Member]                                  
Stock options vesting description                 Which per the Consulting Agreement with the consultant will vest monthly over next twelve months.                
Unvested shares of common stock                 6,137                
Stock-based compensation                 $ 69,176                
MZ Agreement [Member]                                  
Number of common stock issed, value           $ 135,150                      
Stock-based compensation           121,079                      
Compensation per month, value           $ 8,000                      
MZ Agreement [Member] | Restricted Stock [Member]                                  
Number of restricted shares vested           85,000                      
Vesting period           6 months                      
Initial Public Offering [Member]                                  
Number of common stock shares issued   3,615,622                              
Gross proceeds from initial public offering   $ 3,868,716                              
Cash offering costs   $ 549,060                             $ 967,573
Stock issued price per shares   $ 1.07                              
Private Placement Offering [Member]                                  
Cash offering costs                               $ 386,724  
Additional Units [Member]                                  
Number of common stock shares issued                     225,000            
Sale of stock description                     On June 8, 2018, the underwriters notified the Company of their exercise in full of their option to purchase an additional 225,000 Units (the "Additional Units") to cover over-allotments.            
Additional Units [Member] | Initial Public Offering [Member]                                  
Sale of stock price per share                   $ 5.00              
Gross proceeds from initial public offering                   $ 1,125,000              
Chief Medical Officer [Member]                                  
Number of common stock shares issued                             44,444    
Number of common stock issed, value                             $ 200,000    
Chief Medical Officer [Member] | Service Agreement [Member]                                  
Monthly fee                           $ 15,000      
Sole option payable monthly fee description                           Its sole option, elect to pay 25% of the monthly fee in company common stock with the number of common stock determined by dividing the 25% of the monthly fee by the closing price of the Company's common stock on the 2nd work day of each month.      
Dividing percentage                           25.00%      
Medical Advisory Board [Member]                                  
Number of common stock shares issued                 30,000                
Number of common stock issed, value                 $ 90,000                
Consultants [Member]                                  
Number of common stock shares issued                 160,000                
Number of common stock issed, value                 $ 798,400                
Share based compensation granted, shares                 20,000                
Stock option grant fair value                 $ 99,800                
Accredited Investors [Member] | Share Purchase Agreement [Member]                                  
Sale of stock price per share         $ 1.15                        
Gross proceeds raised in private placement offering         $ 2,704,000                        
Aggregate number of shares sold in the offering         2,329,615                        
Accredited Investors [Member] | Private Placement Offering [Member] | Share Purchase Agreement [Member]                                  
Cash offering costs         $ 386,724                        
Chief Executive Officer [Member]                                  
Number of common stock shares issued         18,382                        
Stock issued price per shares         $ 1.36                        
Consultant [Member] | Consulting Agreement [Member]                                  
Number of unvested shares were returned       6,137                          
Dr. Francis Duhay [Member]                                  
Number of restricted shares of common stock 9,728                                
Dr. Francis Duhay [Member] | Restricted Stock Units [Member]                                  
Stock-based compensation $ 19,164                                
Number of restricted shares of common stock 9,728                                
[1] net of offering costs of $549,060.
[2] net of offering costs of $2,542,555
[3] Net of cash offering costs of $967,573.
[4] Net of cash offering costs of $386,724.